Solvonis Therapeutic reports vital patent milestone achieved for SVN 114
Solvonis Therapeutics PLC said a vital patent milestone has been achieved for SVN 114, according to an RNS announcement dated 03 September 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.